XTX202 in Patients With Advanced Solid Tumors
NCT05052268
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
XTX202
Sponsor
Xilio Development, Inc.